Crossref
Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study
American Journal of Cancer Research · 2026 · 16 (10) · 4637-4648
DOI: 10.62347/dfep8664 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Qianwen Gao und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gao, Q., & Jin, L. (2026). Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study. American Journal of Cancer Research, 16(10), 4637-4648. https://doi.org/10.62347/dfep8664
Vancouver
Gao Q, Jin L. Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study. American Journal of Cancer Research. 2026;16(10):4637-4648. doi:10.62347/dfep8664
BibTeX
@article{Gao2026,
author = {Gao, Qianwen and Jin, Lin},
title = {Efficacy and adverse reaction risk factors of immunotherapy in advanced non-small cell lung cancer: a retrospective study},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {10},
pages = {4637--4648},
doi = {10.62347/dfep8664}
}
EUVIMED